Endogenous and Exogenous Stimuli-Responsive Drug Delivery Systems for Programmed Site-Specific Release. 2019

Ali Raza, and Tahir Rasheed, and Faran Nabeel, and Uzma Hayat, and Muhammad Bilal, and Hafiz M N Iqbal
School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China. aliraza86@sjtu.edu.cn.

In this study, we reviewed state-of-the-art endogenous-based and exogenous-based stimuli-responsive drug delivery systems (DDS) for programmed site-specific release to overcome the drawbacks of conventional therapeutic modalities. This particular work focuses on the smart chemistry and mechanism of action aspects of several types of stimuli-responsive polymeric carriers that play a crucial role in extracellular and intracellular sections of diseased tissues or cells. With ever increasing scientific knowledge and awareness, research is underway around the globe to design new types of stimuli (external/internal) responsive polymeric carriers for biotechnological applications at large and biomedical and/or pharmaceutical applications, in particular. Both external/internal and even dual/multi-responsive behavior of polymeric carriers is considered an essential element of engineering so-called 'smart' DDS, which controls the effective and efficient dose loading, sustained release, individual variability, and targeted permeability in a sophisticated manner. So far, an array of DDS has been proposed, developed, and implemented. For instance, redox, pH, temperature, photo/light, magnetic, ultrasound, and electrical responsive DDS and/or all in all dual/dual/multi-responsive DDS (combination or two or more from any of the above). Despite the massive advancement in DDS arena, there are still many challenging concerns that remain to be addressed to cover the research gap. In this context, herein, an effort has been made to highlight those concerning issues to cover up the literature gap. Thus, the emphasis was given to the drug release mechanism and applications of endogenous and exogenous based stimuli-responsive DDS in the clinical settings.

UI MeSH Term Description Entries
D008027 Light That portion of the electromagnetic spectrum in the visible, ultraviolet, and infrared range. Light, Visible,Photoradiation,Radiation, Visible,Visible Radiation,Photoradiations,Radiations, Visible,Visible Light,Visible Radiations
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010812 Physical Stimulation Act of eliciting a response from a person or organism through physical contact. Stimulation, Physical,Physical Stimulations,Stimulations, Physical
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013696 Temperature The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms. Temperatures

Related Publications

Ali Raza, and Tahir Rasheed, and Faran Nabeel, and Uzma Hayat, and Muhammad Bilal, and Hafiz M N Iqbal
May 2013, Biomaterials,
Ali Raza, and Tahir Rasheed, and Faran Nabeel, and Uzma Hayat, and Muhammad Bilal, and Hafiz M N Iqbal
June 2022, Drug discovery today,
Ali Raza, and Tahir Rasheed, and Faran Nabeel, and Uzma Hayat, and Muhammad Bilal, and Hafiz M N Iqbal
August 2014, Chemical communications (Cambridge, England),
Ali Raza, and Tahir Rasheed, and Faran Nabeel, and Uzma Hayat, and Muhammad Bilal, and Hafiz M N Iqbal
February 2009, Biomacromolecules,
Ali Raza, and Tahir Rasheed, and Faran Nabeel, and Uzma Hayat, and Muhammad Bilal, and Hafiz M N Iqbal
January 2017, Chemical & pharmaceutical bulletin,
Ali Raza, and Tahir Rasheed, and Faran Nabeel, and Uzma Hayat, and Muhammad Bilal, and Hafiz M N Iqbal
January 2022, Pharmaceutics,
Ali Raza, and Tahir Rasheed, and Faran Nabeel, and Uzma Hayat, and Muhammad Bilal, and Hafiz M N Iqbal
January 2023, Frontiers in bioengineering and biotechnology,
Ali Raza, and Tahir Rasheed, and Faran Nabeel, and Uzma Hayat, and Muhammad Bilal, and Hafiz M N Iqbal
May 2020, Molecular pharmaceutics,
Ali Raza, and Tahir Rasheed, and Faran Nabeel, and Uzma Hayat, and Muhammad Bilal, and Hafiz M N Iqbal
December 2016, Molecules (Basel, Switzerland),
Ali Raza, and Tahir Rasheed, and Faran Nabeel, and Uzma Hayat, and Muhammad Bilal, and Hafiz M N Iqbal
August 2021, Biomaterials,
Copied contents to your clipboard!